Wednesday, June 20, 2018 5:59:44 PM
However, I have been expecting this (as I’m sure others have) and am surprised that they went this long without an increase. An educated guess is that they need this to ramp up production (their orders to their manufacturers in China [if memory serves, that’s where they are]) along with their other ongoing costs (510k application, legal costs related to the SEC matter, redesign of packaging including KT tape, etc.)
Looks like full clearance and Dr. Scholl’s/Bayer may happen by the end of the summer and then the 5 bln increase will be only a blip on the trajectory of BIEL’s SP.
As filings go, this is much better than a RS, and the increase is relatively modest. AW has said NHS should increase UK sales by multiples, so that may make this AS increase the last one. Assuming they don’t have a Tesla issue of their costs outpacing their profits, NHS sales allow them to meet their ongoing expenses and they turn profitable by a few dollars.
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM
Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • ELMGF • Sep 18, 2024 10:29 AM
Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • MFL • Sep 17, 2024 9:02 AM
PickleJar Announces Integration With OptCulture to Deliver Holistic Fan Experiences at Venue Point of Sale • PKLE • Sep 17, 2024 8:00 AM